Literature DB >> 17048305

Up-regulation interleukin-6 and interleukin-8 by activated protein C in lipopolysaccharide-treated human umbilical vein endothelial cells.

Yi Li1, Bin Du, Jia-qi Pan, De-chang Chen, Da-wei Liu.   

Abstract

OBJECTIVE: To investigate the effect of activated protein C (APC) on inflammatory responses in human umbilical vein endothelial cells (HUVEC) stimulated with lipopolysaccharide (LPS).
METHODS: The second passage of collagenase digested HUVEC was divided into the following groups: serum free medium control group (SFM control), phosphate buffer solution control group (PBS control), LPS group with final concentration of 1 microg/ml (LPS group), APC group with final concentration of 7 microg/ml, Pre-APC group (APC pretreatment for 30 min prior to LPS challenge), and Post-APC group (APC administration 30 min after LPS challenge). Supernatant was harvested at 0, 4, 8, 12 and 24 h after LPS challenge. Interleukin-6 (IL-6) and Interleukin-8 (IL-8) levels were analyzed with ELISA. Cells were harvested at 24 h after LPS challenge, and total RNA was extracted. Messenger RNA levels for IL-6 and IL-8 were semi-quantitatively determined by RT-PCR.
RESULTS: Compared with control group, IL-6 and IL-8 levels steadily increased 4 to 24 h after LPS stimulation. APC treatment could increase LPS-induced IL-6 and IL-8 production. The mRNA levels of IL-6 and IL-8 exhibited a similar change.
CONCLUSION: APC can further increase the level of IL-6 and IL-8 induced by LPS. The effect of these elevated cytokines is still under investigation.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17048305      PMCID: PMC1635816          DOI: 10.1631/jzus.2006.B0899

Source DB:  PubMed          Journal:  J Zhejiang Univ Sci B        ISSN: 1673-1581            Impact factor:   3.066


  21 in total

Review 1.  Introduction: are natural anticoagulants candidates for modulating the inflammatory response to endotoxin?

Authors:  C T Esmon
Journal:  Blood       Date:  2000-02-15       Impact factor: 22.113

Review 2.  Phylogenetic and functional relationships between coagulation and the innate immune response.

Authors:  S M Opal
Journal:  Crit Care Med       Date:  2000-09       Impact factor: 7.598

3.  Activated protein C inhibits lipopolysaccharide-induced nuclear translocation of nuclear factor kappaB (NF-kappaB) and tumour necrosis factor alpha (TNF-alpha) production in the THP-1 monocytic cell line.

Authors:  B White; M Schmidt; C Murphy; W Livingstone; D O'Toole; M Lawler; L O'Neill; D Kelleher; H P Schwarz; O P Smith
Journal:  Br J Haematol       Date:  2000-07       Impact factor: 6.998

4.  Gene expression profile of antithrombotic protein c defines new mechanisms modulating inflammation and apoptosis.

Authors:  D E Joyce; L Gelbert; A Ciaccia; B DeHoff; B W Grinnell
Journal:  J Biol Chem       Date:  2001-02-05       Impact factor: 5.157

5.  Differential effect of tumor necrosis factor-alpha on thrombomodulin gene expression by human monocytoid (THP-1) cell versus endothelial cells.

Authors:  S T Grey; V Csizmadia; W W Hancock
Journal:  Int J Hematol       Date:  1998-01       Impact factor: 2.490

6.  Caring for the critically ill patient. High-dose antithrombin III in severe sepsis: a randomized controlled trial.

Authors:  B L Warren; A Eid; P Singer; S S Pillay; P Carl; I Novak; P Chalupa; A Atherstone; I Pénzes; A Kübler; S Knaub; H O Keinecke; H Heinrichs; F Schindel; M Juers; R C Bone; S M Opal
Journal:  JAMA       Date:  2001-10-17       Impact factor: 56.272

7.  IL-6 inhibits lipopolysaccharide-induced tumor necrosis factor production in cultured human monocytes, U937 cells, and in mice.

Authors:  D Aderka; J M Le; J Vilcek
Journal:  J Immunol       Date:  1989-12-01       Impact factor: 5.422

8.  Protein C prevents the coagulopathic and lethal effects of Escherichia coli infusion in the baboon.

Authors:  F B Taylor; A Chang; C T Esmon; A D'Angelo; S Vigano-D'Angelo; K E Blick
Journal:  J Clin Invest       Date:  1987-03       Impact factor: 14.808

9.  Culture of human endothelial cells derived from umbilical veins. Identification by morphologic and immunologic criteria.

Authors:  E A Jaffe; R L Nachman; C G Becker; C R Minick
Journal:  J Clin Invest       Date:  1973-11       Impact factor: 14.808

10.  A meta-analysis of controlled trials of recombinant human activated protein C therapy in patients with sepsis.

Authors:  Christian J Wiedermann; Nicole C Kaneider
Journal:  BMC Emerg Med       Date:  2005-10-14
View more
  2 in total

1.  Use of activated protein C has no avail in the early phase of acute pancreatitis.

Authors:  Sinan Akay; Omer Ozutemiz; Cigdem Yenisey; Nilufer Genc Simsek; Gul Yuce; Yucel Batur
Journal:  HPB (Oxford)       Date:  2008       Impact factor: 3.647

2.  Effects of lipopolysaccharide and Mannheimia haemolytica leukotoxin on bovine lung microvascular endothelial cells and alveolar epithelial cells.

Authors:  David McClenahan; Katrina Hellenbrand; Dhammika Atapattu; Nicole Aulik; David Carlton; Arvinder Kapur; Charles Czuprynski
Journal:  Clin Vaccine Immunol       Date:  2007-11-21
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.